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Cynthia R. Muller1, Ozlem Yalcin2 and Pedro Cabrales1*
1 Department of Bioengineering, University of California, San Diego, San Diego, CA, United States, 2 School of Medicine, Koç
University, Istanbul, Turkey
Acclimatization to hypoxia or high altitude involves physiological adaptation processes,
to influence oxygen (O2) transport and utilization. Several natural products, including
aromatic aldehydes and isothiocyanates stabilize the R-state of hemoglobin (Hb),
increasing Hb-O2 affinity and Hb-O2 saturation. These products are a counter intuitive
therapeutic strategy to increase O2 delivery during hypoxia. 5-Hydroxymethylfurfural
(5-HMF) is well known Amadori compound formed during the Maillard reaction (the non-
enzymatic browning and caramelization of carbohydrate-containing foods after thermal
treatment), with well documented effects in Hb-O2 affinity. This study explores the
therapeutic potential of 5-HMF on left ventricular (LV) cardiac function (LVCF) during
hypoxia. Anesthetized Golden Syrian hamsters received 5-HMF i.v., at 100 mg/kg and
were subjected to stepwise increased hypoxia (15, 10, and 5%) every 30 min. LVCF was
assessed using a closed chest method with a miniaturized conductance catheter via
continuous LV pressure-volume (PV) measurements. Heart hypoxic areas were studied
using pimonidazole staining. 5-HMF improved cardiac indices, including stroke volume
(SV), cardiac output (CO), ejection fraction (EF), and stroke work (SW) compared to the
vehicle group. At 5% O2, SV, CO, EF, and SW were increased by 53, 42, 33, and 51%
with 5-HMF relative to vehicle. Heart chronotropic activity was not statistically changed,
suggesting that differences in LV-CF during hypoxia by 5-HMF were driven by volume
dependent effects. Analysis of coronary blood flow and cardiac muscle metabolism
suggest no direct pharmacological effects from 5-HMF, therefore these results can
be attributed to 5-HMF-dependent increase in Hb-O2 affinity. These studies establish
that naturally occurring aromatic aldehydes, such as 5-HMF, produce modification of
hemoglobin oxygen affinity with promising therapeutic potential to increase O2 delivery
during hypoxic hypoxia.
Keywords: 5-HMF, hemoglobin, allosteric effectors, oxygen delivery, conductance catheter, cardiac function, left
ventricle
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INTRODUCTION
Food products are subjected to thermal treatments to assure
microbiological safety, eliminate enzymatic activities, and to
obtain desirable sensory properties. 5-Hydroxymethylfurfural
(5-HMF) is naturally formed during the thermal treatment of
carbohydrate-containing foods because of the Maillard reaction
(non-enzymatic browning or caramelization). 5-HMF is known
as an Amadori compound, resulting from tautomerization
of the N-glycoside of an aldose or the glycosylamine to
the corresponding 1-amino-1-deoxy-ketose via an immine
intermediate (Hodge, 1955; Kurti and Czako, 2005). Therefore,
5-HMF generally is known as an indicator of heating for
a wide range of foods (Rada-Mendoza et al., 2002). Several
factors influence the formation of 5-HMF in foods, including
carbohydrate content, pH, temperature of treatment, and
water content (Hodge, 1955). In general, monosaccharides
(i.e., fructose or glucose) are substrates for 5-HMF production
(Rada-Mendoza et al., 2002). The toxicological relevance of
5-HMF at very high concentrations is minimal (Ulbricht et al.,
1984). However, recent studies showed that 5-HMF orally,
intraperitoneally, or intravenously has a high bioavailability
(Abdulmalik et al., 2005). 5-HMF has a high red cell membrane
permeability, where it increases hemoglobin (Hb) O2 affinity
by stabilizing the R-state of Hb, which has higher O2 affinity
(Abdulmalik et al., 2005). 5-HMF binds covalently with Hb to
form a high-affinity imine Hb adduct in a symmetrical fashion
with the NH2-terminal α Valine-1 of Hb, allosterically shifting the
Hb-O2 equilibrium curve at relatively low 5-HMF concentrations
(Abdulmalik et al., 2005).
Acute mountain sickness (AMS) is frequently diagnosed in
unacclimated individuals who ascend to 2300 m of altitude or
higher, and studies have shown that an upward of 25% of travelers
experience symptoms (Roach and Hackett, 2001; Basnyat and
Murdoch, 2003). The severity of symptoms can vary with the
degree of the altitude of acclimatization and are a result of
the many physiological responses to a hypoxic environment.
Exposure to these hypoxic conditions reduces O2 transport
from the air to the tissues by blood. The fate of the cardiac
tissue is ultimately determined the balance between myocardial
O2 delivery (MDO2) and consumption (MVO2). MDO2 is
defined by coronary blood flow and O2 saturation, whereas
MVO2 is determined by myocardial O2 tension, heart rate
(HR), contractile state, basal resting metabolism, and the work
performed by the heart (Sonnenblick et al., 1968). Therefore,
during hypoxic hypoxia, coronary blood flow needs to increase to
preserve MVO2. The normal myocardium is known to have good
tolerance to hypoxic conditions. When subjects were exposed to a
simulated altitude of 4500 m by adjusting the fraction of inspired
O2 (FiO2), they experienced an increase in coronary blood flow to
maintain cardiac tissue oxygenation (Wyss et al., 2003). However,
subjects with a history of cardiac diseases showed the opposite
reaction; at a simulated altitude of 2500 m, these patients were
observed to have an 18% reduction in coronary blood flow,
whereas their healthy counterparts showed a 10% increase in
coronary blood flow (Wyss et al., 2003). Thus, acclimatization to
hypoxia requires increases in coronary blood flow to preserve O2
delivery to the cardiac tissue. Inability to increase cardiac output
(CO) during hypoxic hypoxia would limit O2 delivery to the brain
and other vital organs.
Oxygen transport and delivery is carried out by red blood cells
(RBCs), where O2 reversibly binds to Hb. When FiO2 is reduced
(hypoxic hypoxia), arterial pO2 and Hb-O2 saturation decrease,
limiting tissue O2 delivery (MairbÄurl et al., 1986). Exposure to
moderate hypoxia leads to a right shift in the Hb-O2 binding
curve, facilitating O2 offload to tissues typically mediated by an
increase in the RBCs 2,3-diphosphoglycerate concentration (2,3-
DPG), decrease in the pH of blood (Bohr Effect), and an increase
in CO2 (Haldane Effect) (Hebbel et al., 1978). Decreased Hb-O2
affinity during hypoxic hypoxia leads to a more drastic reduction
in O2 uptake in the lungs, decreasing arterial O2 saturation, and
limiting the adaptive response to hypoxia. However, birds and
mammals that live at high altitudes have adapted to hypoxia
by genetically increasing Hb affinity for O2. Their increased
O2 affinity Hb favors O2 uptake in the lungs, thus increasing
arterial O2 saturation during hypoxic hypoxia (Black and Tenney,
1980; Storz, 2007).
Left shifting the Hb-O2 equilibrium curve (OEC) secures
O2 at the pulmonary level during hypoxic hypoxia, increasing
O2 carrying capacity (OCC), and preserving O2 delivery
independent of blood flow. This study aims to evaluate the
effect of increased Hb-O2 affinity with 5-HMF in left ventricle
(LV) cardiac function (LVCF) during hypoxia. We hypothesize
that increasing Hb-O2 affinity with exogenously administered 5-
HMF would increase arterial O2, allowing for superior coronary
O2 delivery and preservation of LVCF at extreme hypoxia, and
support systemic O2 delivery. Previous studies by our group
determined that animals treated with 5-HMF had a decrease in
blood P50 (partial pressure of O2 at which Hb is 50% saturated
with O2) by up to 15 mmHg, providing increased microvascular
O2 delivery during anemia and 5% O2 hypoxia (Yalcin and
Cabrales, 2012). In this study, we aim to further inquire into
the mechanical response of the heart, using a miniaturized
conductance catheter to measure the ventricular PV changes
during hypoxic challenges. Changes in oxygen distribution in the
microcirculation due to 5-HMF were studied using hyperspectral
images (HSI) of hamster window chamber models. Finally,
potential effects of 5-HMF in cardiac muscle metabolism were
assessed through isolated mouse heart studies.
MATERIALS AND METHODS
Animal handling and care followed the NIH Guide for
Care and Use of Laboratory Animals. The experimental
protocol was approved by the UCSD Institutional Animal Care
and Use Committee.
Animal Preparation
Studies were performed in male Golden Syrian hamsters
(80–90 g, Charles River Laboratories, Boston, MA,
United States). The experimental protocol is similar to that
reported in a previous study by our group (Ao-Ieong et al., 2017).
Animals were initially anesthetized using sodium pentobarbital
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(40 mg/kg IP). Subsequently, the animals were implanted
with left jugular vein and left femoral artery catheters. A LV
conductance catheter was introduced through the right carotid
artery. A tracheotomy was performed (polyethylene-90 tube),
and animals were ventilated (TOPO ventilator, Kent Scientific,
Torrington, CT, United States) at a respiration rate of 90
breaths/min and peak inspiratory pressure of 20 cmH2O to aid
with breathing in the supine position. Animals were placed on
a heating pad to maintain core body temperature at 37 ◦C and
after instrumentation, volatile anesthesia (0.6%/vol Isoflurane,
Drägerwerk AG, Lübeck, Germany) was administered using a
vaporizer connected to the ventilator to preserve the depth of
anesthesia during the experimental protocol. Depth of anesthesia
was continually verified via toe pinch, and, if needed, isoflurane
concentration was increased by 0.1%/vol to prevent animal
discomfort. Experimental setup is presented in Figure 1C.
Inclusion Criteria
Animals were suitable for the experiments if: (i) mean arterial
blood pressure (MAP) was above 80 mmHg at baseline, (ii)
stroke volume (SV) was above 18 µL at baseline, (iii) systemic
hematocrit was above 45%, (iv) HR was above 350 bpm at
baseline, and (v) CO was above 8 mL/min at baseline.
Cardiac Function
A 1.4F pressure volume (PV) conductance catheter (SPR-839,
Millar Instruments, TX, United States) was inserted into the LV
using the closed chested method (Pacher et al., 2008). Briefly,
the PV catheter inserted through the exposed right carotid artery
and slowly advanced, passing through the aortic valve, into the
LV. Pressure and volume signals were acquired continuously
(MPVS3000, Millar Instruments, Houston, TX, United States
and PowerLab 8/30, AD Instruments, Colorado Springs, CO,
United States). Left ventricular volume was measured in
conductance units (relative volume unit, RVU) and converted to
absolute blood volume (µL) at the end of the experiment (Pacher
et al., 2008; Doyle et al., 2016). Parallel volume was calibrated at
the end of the experiment via IV injection of 10 µL hypertonic
saline (10% NaCl) (Pacher et al., 2008).
Cardiac Pressure-Volume Indices
Cardiac function was analyzed using PVAN software (PVAN
3.6, Millar Instruments, TX, United States). Cardiac function
parameters were calculated from 20 to 25 cardiac cycles at
each time point. SV, stroke work (SW), CO, ejection fraction
(EF), cardiac contractility (dP/dt/VEd), and arterial elastane (Ea)
were directly calculated in the PVAN software. Systemic vascular
resistance (SVR) was calculated as: SVR = MAPCO . Internal energy
utilization (IEU) was used as a measure of internal metabolism
of the LV (Doyle et al., 2013), and it was calculated as IEU =
([Ves − V0] ∗Pes)/2, where Ves is the end systolic volume, V0
is the ESPV volume axis intercept, and Pes is the end systolic
pressure. Using the assumption that end systolic PV curve
intercept is small, V0 was set to zero for the calculations.
LV mechanical efficiency (VME) was defined and calculated
as: VME = SWPVA ,where PVA is the total PV area given by:
PVA = (IEU+ SW). Oxygen delivery (DO2) was calculated as:
DO2 = CO∗(1.34∗HCT∗SaO2 + 0.003∗pO2).
Hypoxia Protocol
After surgery, animals were kept under normoxia for 30 min,
after which baseline measurements were taken. Then, twelve
animals (N = 12) were randomly assigned to receive either 100
uL of sterile saline with 100 mg/kg 5-HMF (Sigma-Aldrich, St.
Louis, MO, United States) or only saline 20 min before exposure
to hypoxia. This dosage is based in previous in vivo mice studies,
where a single 100 mg/kg oral dose was efficacious in prolonging
survival under severe hypoxia (Abdulmalik et al., 2005). The
same study found that a maximum plasma concentration of 5-
HMF at 30 min after infusion for doses of 100 mg/kg, therefore
by initiating hypoxia at 20 min post infusion ensures that the
maximum plasma concentration is achieved during hypoxia. Six
animals were assigned to each group. Animals were subjected
to 30 min challenge of 15% hypoxia, then to 30 min challenge
of 10% hypoxia, and lastly to 30 min challenge of 5% O2
hypoxia. Cardiac function measurements were taken 25 min into
respective hypoxic stage. Representation of experimental timeline
is presented in Figure 1B.
Systemic Hemodynamics Parameters
Mean arterial blood pressure and heart rate were recorded
continuously from the femoral artery (PowerLab 8/30, AD
Instruments, Colorado Springs, CO, United States). Hematocrit
was measured from centrifuged arterial blood samples taken
in heparinized capillary tubes. Hb content was determined
spectrophotometrically (B-Hemoglobin; Hemocue, Stockholm,
Sweden). Arterial blood was collected in heparinized glass
capillary tubes (50 uL) and immediately analyzed for arterial
oxygen tension (pO2), arterial carbon dioxide partial pressure
(pCO2), and pH (RapidLab 248; Bayer, Norwood, MA,
United States). Ventricular PV measurements were continuously
measured (PowerLab 8/30, AD Instruments, Colorado Springs,
CO, United States).
Oxygen Equilibrium Curve (OEC)
Blood OECs were measured using a TCS Hemox Analyzer (TCS
Scientific Company) at the end of the experiment. To measure
changes in the O2 affinity, blood samples were diluted 100X-fold
in TCS Hemox buffer. In the Hemox Analyzer, samples were first
saturated with compressed air (21% O2) and then deoxygenated
with pure nitrogen. The absorbance of Hb at 570 nm and at
560 nm were recorded as a function of the O2 tension. The P50
were calculated using regression analysis with the TCS Hemox
analyzer software.
Histology
Immunohistochemistry staining for pimonidazole bound to
hypoxic zones in vital tissues during hypoxia was completed via
IV injection of the hypoxic marker Hypoxyprobe-1 (40 mg/kg
pimonidazole, Hypoxyprobe, Burlington, MA, United States) and
5 mg/kg Hoechst 33342 (Invitrogen, Carlsbad, CA, United States)
diluted in PBS (total volume 100 µL) 5 min before 10% hypoxia.
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FIGURE 1 | (A) Changes in blood Hb-O2 equilibrium during normoxia and hypoxia. 5-HMF increased blood Hb-O2 equilibrium in a dose dependent matter. At 10
and 5% O2, arterial Hb-O2 saturation should be higher with a left shift in the Hb-O2 dissociation curve (Kurti and Czako, 2005). (B) Hypoxia scheme followed in the
experiments.After 5-HMF or the vehicle, animals were exposed to hypoxia by decreasing the fraction of inspired O2 (FiO2)stepwise from 15% to 10%,
and then to 5% O2. Each hypoxic step was maintained for 30 min. (C) Representation of the experimental setup. Hamster was maintained on a 37◦C heated platform.
(Continued)
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FIGURE 1 | Continued
Tracheotomy was performed to achieve consistent mechanical ventilation and volatile anesthesia administration. Compressed gases (100% O2 and 100% N2) were
connected to a flowmeter tonometer to adjust achieve desired FiO2. Flowmeter tonometer provided gases to anesthesia vaporizer and ventilator. Conductance
catheter (MPVS3000, Millar Instruments) was inserted through the carotid artery and advanced to the LV. Femoral artery was catheterized for blood samples and
blood pressure measurements. Jugular vein was catheterized for fluid infusions. CF and MAP measurements were collected using data acquisition hardware
(PowerLab 8/30, AD Instruments), attached to a personal computer, and stored for off-line analysis using PVAN software (PVAN 3.6, Millar Instruments). Parallel
volume was calibrated at the end of the experiment via IV injection of 10 µL hypertonic saline (10% NaCl) (Pacher et al., 2008).
The hearts were immediately excised after euthanasia and fixed
with a 10% glutaraldehyde solution. Consecutive six parasternal
short axis (PSS, cross-sectional “slice”) sections of the heart were
created. Six to 10 random areas per slide were analyzed for
positive pimonidazole staining.
Oxygen Distribution During Acute
Hypoxia
Golden Syrian hamsters (80–90 g, Charles River Laboratories,
Boston, MA, United States) were implanted with dorsal skinfold
window chamber following the same approach described in
previous studies (Tsai et al., 2003; Yalcin and Cabrales, 2012).
Prior to imaging, the animal was placed inside a restraining
tube with the window chamber protruding out of the tube.
A stage securing the tube was fixed to the microscope stage
for intravital microscopy evalaution (BX51WI; Olympus, New
Hyde Park, NY, United States). Arterioles and venules were
mapped across the visible region of the chamber (Tsai et al.,
2003), and their location was noted for future analysis with
the hyperspectral system. After chamber mapping, the animal
dorsal window was imaged using a Pika L hyperspectral imaging
system (Resonon Inc., Bozeman, MT, United States) from which
HSI of the microcirculation where acquired. The white reference
reflectance spectra (Rref) of the system was calibrated using
a white Teflon slab. The animal was allowed to rest in the
tube environment for 20 min at normoxia before imaging.
Images were taken at normoxia, and immediately after exposure
to 10% oxygen for 1 min. Images were taken following the
previously described approach at baseline and after 5-HMF
(400 mg/kg). 5-HMF was given immediately after imaging the
previous hypoxic trial, and 15 min were allowed before the
next hypoxic trial.
Each HSI contained wavelength bands from 450 nm to
600 nm with a spacing of 5 nm between adjacent bands.
Vessels were segmented from the background using a Gabor
filter bank ranging from 0 to 360 degrees in the resulting
image of the ratio between band 575 and band 485, which
previous experiments have shown has maximum Hb contrast,
independent of saturation. The saturation of Hb in the vessel
was determined through a pixel-by-pixel least-squares spectral
fit according to Equation 1, following an approach adapted from
Hendargo et al. (2015).
ε (λ) = b0 + b1εHb (λ)+ b2εHbO2(λ) (1)
Where ε (λ) is the absorbance spectra of any given pixel,
given by ε (λ) = log
(
Rref(λ)
R(λ)
)
, where Rref is the white reference
reflectance spectra, and R is the reflectance spectra from the HSI.
εHb corresponds to the standard absorbance of deoxyhemoglobin
and εHbO2 to the standard absorbance of oxyhemoglobin. The
b0−b2 are the coefficients determined by least-squares, where
b0 accounts for any offset, and b1 and b2 are proportional to
the amount of deoxy- and oxyhemoglobin, respectively. Once
the coefficients were determined, the saturation was calculated
according to Equation 2:
SO2 = b2b1 + b2 × 100% (2)
Heart Isolation and Perfusion
Studies were performed in ten male Sprague-Dawley rats
(Harlan Laboratories, Indianapolis, IN, United States) weighing
200–250 g, with 5 rats were assigned to each group. Animal
handling and care followed the NIH Guide for Care and
Use of Laboratory Animals. The experimental protocol was
approved by the UCSD Institutional Animal Care and Use
Committee. Rats were heparinized (100 U i.p.) 15 min before
anesthesia with 60 mg/kg of pentobarbital sodium (IP). Hearts
were excised and placed in ice-cold Krebs-Henseleit bicarbonate
(KHB) solution. All extraneous tissues were removed, and the
aorta was cannulated with plastic cannula. After cannulation, the
heart underwent a retrograde Langendorff perfusion (60 mmHg
perfusion pressure) with KHB solution for, 15 min. At this
time, the left atrium was connected to the preload reservoir by
cannulating the pulmonary vein. The perfusate reservoir was
used to control preload line, and was wrapped with a water
jacket and heated to 38.7◦C and, which resulted in a myocardial
temperature around 37◦C. Heart was switched from Langendorff
to working mode and perfused at constant preload pressure of
15 mmHg LV worked against a hydrostatic column set at a height
equivalent to a pressure of 50 mmHg. Pressure development in
the aortic (afterload) line was measured using a 2.5-Fr transducer
(Millar Instruments, Houston, TX, United States). Pressure
measurements were recorded continually. HR was determined
from the pressure traces. Coronary flow measurements were
obtained by collecting the effluent dripping off the heart.
Perfusate Solutions
The KHB solution used for the initial Langendorff perfusion
consisted of 118.5 mM NaCl, 25 mM NaHCO3, 4.7 mM KCl,
1.2 mM MgSO4, 1.2 mM KH2PO4, 2.5 mM CaCl2, 0.5 mM
EDTA, and 11 mM glucose and was gassed with 95% O2-
5% CO2 (pH 7.4). The working heart solution used in this
experiment was a modified KHB solution containing palmitate
(0.5 mM) bound to 3% bovine serum albumin (BSA) as a
metabolic substrate in addition to 11 mM glucose. Working
heart solution was continuously gassed with various oxygen
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concentrations balanced with 5% CO2 to achieve set oxygen
tensions in the solution. Hearts were studied with working heart
solutions or working heart solution with 3 mM 5-HMF. Glucose
and palmitate were used because they are the most abundant
metabolic substrates for cardiac energy metabolism. They allow
for the evaluation of glucose utilization (glycolysis and oxidation)
and fatty acid oxidation in isolated working hearts perfused with
isotopic glucose and palmitate.
Measurement of Substrate Metabolism
Metabolism of isotopic labeled glucose was measured as outlined
before (Saddik and Lopaschuk, 1991). All determinations of
substrate metabolism were made in duplicate. Rates of glycolysis
and glucose oxidation were measured simultaneously. Steady-
state metabolic rates were calculated as the mean values when
perfusate samples were collected from the working heart.
Metabolic rates obtained for the various metabolic pathways
were normalized for heart mass (dry wt). Glycolytic flux was
determined by measuring the amount of 3H2O released from the
metabolism of 5-[3H]glucose by the triosephosphate isomerase
and enolase steps of the glycolytic pathway. To separate 3H2O
from 5-[3H]glucose and [U-14C]glucose, perfusate samples were
separated using an anion exchange columns. Briefly, a 100 µL
sample was loaded on the column and eluted into scintillation
vials with 0.8 mL of H2O. Samples were counted for 3H and 14C.
Glucose oxidation was determined by measuring 14CO2 released
by the metabolism of [U-14C] glucose. The 14CO2 released
during glucose oxidation was trapped by bubbling the outflow air
through 1M hyamine hydroxide. The 14CO2 left in the form of
bicarbonate anion solution in the perfusion medium was released
with KHB solution. Total 14CO2 production included the 14CO2
in the outflow air and the perfusion solution.
Statistical Analysis
Results are presented as mean ± standard deviation. The
measured hemodynamic, blood gases, pH and lactate parameters
are presented as absolute values. The measured cardiac function
parameters are presented relative to the baseline values. A ratio
of 1.0 signifies no change from the baseline, whereas lower or
higher ratios are indicative of changes proportionally lower or
higher compared to baseline. The Grubbs’ method was used
to assess closeness for all measured parameters at baseline.
Statistically significant changes between groups and different
FiO2 values were analyzed using two-way ANOVA with multiple
comparisons. All statistics were calculated using GraphPad
Prism 6 (GraphPad, San Diego, CA). Results were considered
statistically significant if P < 0.05.
RESULTS
Twelve animals were included in the hypoxic challenge study,
5-HMF (100 mg/kg; n = 6); and Vehicle (n = 6). All animals
tolerated the experimental protocol without signs of stress or
discomfort. Animals passed the Grubbs’ test, ensuring that all
parameters at baseline were within a similar population (P> 0.3).
After administration of 5-HMF or the vehicle, animals were
exposed to hypoxia by decreasing the % O2 stepwise from 15%
to 10%, and then to 5% O2. Each hypoxic step was maintained for
30 min (Figure 1B).
Changes in Blood O2 Affinity
Administration of 5-HMF or exposure to hypoxia caused
no significant changes in the Hct and Hb (Table 1). Single
administration of 5-HMF at 100 mg/kg decreased the P50 from
32.2 ± 0.5 mmHg to 21.6 ± 1.2 mmHg in the 5-HMF group
(P < 0.05), but did not have any effect in the vehicle groups
[P50 = 32.4 ± 0.7 mmHg (Table 1), representative shift in P50
is shown in Figure 1A]. Single administration of 5-HMF at
400 mg/kg, as used to determine arteriolar and venular Hb-O2
saturation in the dorsal window using HSI, decreased the P50 to
17.2± 0.9 mmHg. Changes in P50 with 5-HMF were maintained
throughout the entire duration of the protocol.
Systemic and Blood Chemistry
Systemic hemodynamics and blood gases are presented in
Figure 2. MAP remained unchanged when first exposed to
moderate hypoxia of 15% O2 and decreased as hypoxia became
more severe in both groups (Figure 2A). At 10% and 5% O2,
the animals treated with 5-HMF showed higher MAP than the
vehicle group, but no statistically significant differences were
seen. Similarly, no significant changes in HR were observed
between hypoxia levels or treatment groups, however, the 5-
HMF group had a lower median HR at 5% O2 (Figure 2B).
Both pO2 and pCO2 decreased with hypoxia (Figures 2C,D).
5-HMF resulted in slightly higher pCO2 and pO2 compared to
vehicle, however, no statistical difference was observed between
the groups. As expected, pH decreased with decreased O2
concentration, and the vehicle group had a significantly more
acidic pH at 10 and 5% FiO2 concentrations relative to the 5-
HMF group at the same O2 concentrations (Figure 2E). Blood
lactate levels increased with hypoxia in both groups, and the
5-HMF group had significantly lower lactate compared to the
vehicle group at 5% O2 (P < 0.05, Figure 2F). Arterial O2
saturation (SaO2) decreased in both groups; however, the vehicle
group had a statistically significant lower SaO2 at 10 and 5%
O2 compared to the 5-HMF group (P < 0.05). At 15 and 10%
FiO2 there were no significant differences in SaO2 for the 5-HMF
group, whereas the vehicle group had statistically significant
lower SaO2 at 10%.
TABLE 1 | Blood O2 Carrying capacity and O2 affinity.
Baseline Groups
Hct (%) 49.1 ± 1.1 5-HMF 48.9 ± 0.7
Vehicle 49.3 ± 0.9
Hb (g/dl) 14.8 ± 0.8 5-HMF 14.7 ± 0.6
Vehicle 14.9 ± 0.5
P50 (mmHg) 32.2 ± 0.5 5-HMF 21.6 ± 1.2∗
Vehicle 32.4 ± 0.7
Values represent means ± SD. Baseline included all the animals in the study. No
significant differences were detected at baseline between groups, before treatment.
∗represents statistically significant differences (P < 0.05) compared to vehicle
according to an unpaired t-test.
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FIGURE 2 | (A) Mean arterial blood pressure (MAP), (B) heart rate (HR), (C) arterial oxygen tension (pO2), (D) arterial partial pressure of carbon dioxide (pCO2), (E)
arterial pH, and (F) arterial lactate during the long-term hypoxia protocol. (G) Shows the HbO2 saturation calculated from the pO2 and the Hill equation for HbO2
dissociation with and without 5-HMF. The p50 value used for the 5-HMF treated and vehicle groups are shown in Table 1. Symbols represent statistically significant
differences (P < 0.05): ∗ relative to 21% FiO2, † relative to 15% FiO2, and ‡ relative to 10% FiO2.
Cardiac Function
All LV indices of function are presented normalized to normoxia
and are summarized in Figure 3.
Stroke volume is presented in Figure 3A and remained
unchanged during 15 and 10% O2 hypoxia; however, a
statistically significant decrease in SV was observed in vehicle
group compared to the 5-HMF group at 5% O2 hypoxia
(P < 0.05). The 5-HMF group increased SV by 38% from
normoxia during 5% O2 hypoxia (P < 0.05), while the vehicle
group decreased SV 19% for from normoxia at the same
hypoxic level.
Cardiac output is presented in Figure 3B. During mild
hypoxia (15% O2), the vehicle group showed an 18% increase in
CO from normoxia. However, as hypoxia become more severe,
CO decreased with the severity of hypoxia. At 5% O2, the CO
of the vehicle group was 79% of that in the normoxia. On the
other hand, the CO of the 5-HMF group was preserved during
hypoxia, and increased by 11 and 19% from normoxia at 10 and
5% O2 hypoxia, respectively. CO was statistically higher for the
5-HMF group compared to the vehicle group at 5% O2 hypoxia
(P < 0.05). EF is presented in Figure 3C. EF was statistically
higher for the 5-HMF group compared to the vehicle group at
5% O2 hypoxia (P< 0.05). SW is presented in Figure 3D and was
preserved as hypoxia increased in the 5-HMF groups, whereas in
the vehicle group, SW decreased with the severity of the hypoxia.
SW was statistically higher for the 5-HMF group compared to
the vehicle group at 5% O2 hypoxia (P < 0.01). Contractility, in
terms of dP/dtmax normalized by Ved is presented in Figure 3E,
and remained unchanged during the experiment in both groups.
SVR is presented in Figure 3F, and was observed to decrease
with the severity of hypoxia in the 5-HMF groups, but no
difference in SVR was observed in the vehicle group compared
to normoxia. SVR was statistically lower for the 5-HMF group
compared to the vehicle group at 5% O2 hypoxia (P < 0.01).
IEU is presented in Figure 3G, and it remained unchanged
during the experiment in both groups. LV mechanical efficiency
is presented in Figure 3H and remained unchanged during 15
and 10% O2 hypoxia; however, LV mechanical efficiency was
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FIGURE 3 | Left ventricle (LV) cardiac function (CF) measurements during hypoxia. (A) Stroke volume (SV), (B) cardiac output (CO), (C) ejection fraction (EF), (D)
stroke work (SW), (E) contractility (dP/dtmax/Ved), (F) systemic vascular resistance (SVR), (G) internal energy utilization (IEU), (H) left ventricular mechanical efficiency,
and (I) oxygen delivery (DO2). Symbols represent statistically significant differences (P < 0.05): ∗ relative to 21% FiO2, † relative to 15% FiO2, and ‡ relative
to 10% FiO2.
significantly lower for the vehicle group compared to the 5-HMF
group at 5% O2 (P < 0.01). DO2 is shown in Figure 3I. At 15%,
the vehicle group had a statistically significant increase in DO2
relative to normoxia, and when compared to the 5-HMF group
at 15% FiO2. At 10% FiO2, the 5-HMF group had a statistically
significant increase in DO2 relative to normoxia for the same
group, and relative to the vehicle group at 15% hypoxia, which
had a statistically significant decrease in DO2. Finally, at 5% FiO2,
the DO2 for the 5-HMF group decreased back to baseline levels
when compared to the 10% FiO2 case. When compared to the 5-
HMF group at 5% and the vehicle group at normoxia, 15 and 10%,
the vehicle group at 5% FiO2 had the lowest DO2. The normoxia
values for the different cardiovascular variables for the vehicle
and 5-HMF groups are shown in Table 2. The majority of the
parameters shown in Figure 3 are derived from those variables.
Pimonidazole Staining
5-HMF-induced increased O2 affinity and reduced positive
hypoxic staining by pimonidazole compared to the vehicle group
(Figure 4). In addition, sections closer to the apex were drastically
more hypoxic in the vehicle compared to 5-HMF. At the base
of the heart, 41 ± 7% and 27 ± 5% of the tissue were hypoxic
for the vehicle and 5-HMF group, respectively. The apex of
the heart showed 74 ± 6% and 48 ± 5% positive staining for
the vehicle and 5-HMF group, respectively. Animals treated
with 5-HMF had statistically less hypoxic tissue per slide when
compared to vehicle group (P < 0.05). On average, 5-HMF
reduced hypoxic tissue by 60%.
Oxygen Distribution During Acute
Hypoxia
The saturation maps from the hypoxia experiment are shown
in Figure 5B. Consistently, arterial Hb saturation from
blood gas analysis was 62.7% with 5-HMF and 48.4% with
vehicle during hypoxia. Studying the Hb-O2 saturation in
the dorsal window using HSI indicates that microvascular
saturation during normoxia were distributed between 60
and 90% for venules and arterioles, and decreased to 30
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TABLE 2 | Cardiovascular Parameters at Normoxia (21% FiO2).
Vehicle (n = 6) 5-HMF (n = 5)
HR (BPM)∗ 397.0 ± 41.6 490.6 ± 25.4
MAP (mmHg) 107.6 ± 8.4 112.6 ± 7.2
Ves (µL) 16.0 ± 0.6 16.6 ± 0.9
Ved (µL)∗ 36.1 ± 2.1 36.2 ± 2.2
SV (µL) 20.1 ± 2.4 19.6 ± 2.3
Pes (mmHg) 123.3 ± 8.6 120.8 ± 4.7
Ped (mmHg) 7.2 ± 0.4 7.2 ± 0.5
Values represent means ± SD. ∗ represents statistically significant differences
(P < 0.05) between the two groups according to an unpaired t-test.
to 50% during hypoxia. Treatment with 5-HMF during
normoxia does not appear to affect Hb-O2 saturation of
arterioles and venules in the dorsal window. However,
during hypoxia 5-HMF shifted the Hb-O2 saturation
distribution toward the arterioles, increasing arteriolar Hb
saturations to 60%, and decreasing the venular Hb saturations
to 20%.
Heart Perfusion Studies
Isolated rat hearts were studied with control perfusate and
with perfusate containing 3mM 5-HMF. Coronary blood flow
increases as the O2 tensions of the perfusate was decreased,
with a max coronary blood observed around 30 to 40 mmHg
(Figure 6A). Hypoxia (perfusate equilibrated at 40 mmHg)
increased coronary blood flow increased compared to normoxia
(perfusate equilibrated at 100 mmHg); although no differences
were detected in HR or developed pressure during hypoxia
and normoxia (Figures 6B,C). Addition of 3mM 5-HMF to
the perfusate did not have any effect relative to the use of
the perfusate alone, suggesting that 5-HMF does not have any
pharmacological effect in the heart (Figures 6B,C). Glycolysis,
glucose oxidation and lactate oxidation rates increased during
hypoxia (perfusate equilibrated at 40 mmHg) compared to
normoxia (perfusate equilibrated at 100 mmHg) (Figures 7A–C).
Addition of 3mM 5-HMF to the perfusate did not have any effect
on Glycolysis, glucose oxidation or lactate oxidation rates relative
to the use of the perfusate alone (Figures 7A–C). Therefore,
5-HMF does not appear to have any cardiac metabolic effect.
DISCUSSION
The principal finding of this study was that 5-HMF decreased
hypoxic damage experienced by the heart due to severe hypoxic
hypoxia. Exposure to hypoxia had the expected effect on the
vehicle group, with an increase in CO at first exposure to
hypoxia (15% O2). This corresponds to a moderate level of
hypoxia comparable to what is observed at altitudes of 2400 m,
where the increase in cardiac activity is a common response
to preserve tissue oxygenation (Wyss et al., 2003). As hypoxia
FIGURE 4 | Heart staining for hypoxia with pimonidazole. Positive pimonidazole staining represents areas of hypoxia in the cardiac tissue. Amount of hypoxic areas
increased with the proximity to the heart apex.
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FIGURE 5 | (A) Increasing Hb-O2 affinity during hypoxia with 5-HMF preserves cardiac oxygenation. Representation of the oxygenation in the coronary circulation
during normoxia and hypoxia. Red represents oxygenated blood, blue represents deoxygenated blood. Left, during normoxia, cardiac tissue is well oxygenated.
Center, during hypoxia, O2 is offloaded to the tissues. Right, Increasing Hb-O2 affinity during hypoxia with 5-HMF increases Hb-O2 saturation during hypoxia and
increases coronary O2 delivery. (B) Dorsal skinfold window chamber HSIs. Left, RGB representation of the analyzed region of the chamber. Center, resulting
hemoglobin (Hb) saturation maps at normoxia and hypoxia prior to the administration of 5-HMF. Right, resulting Hb saturation maps at normoxia and hypoxia after
administration of 5-HMF. Colormap for the saturation is presented on the right. Arterial saturation, as measured by an arterial line blood sample, for each timepoint, is
shown in parenthesis. Arterioles in each image are represented by red arrows.
severity increased to 10% O2 and later to 5% O2, the cardiac
tissue started to fail. The mechanical ability of the heart to
pump blood became impaired in the vehicle control group. This
is most evident in the decline of CO, EF, SV, SW, and the
considerable amount of cardiac hypoxic tissue areas seen in the
vehicle group. On the other hand, treatment with 5-HMF resulted
in mild changes in cardiac function at 15% O2 hypoxia. However,
5-HMF-induced increases in Hb-O2 affinity preserved, and in
certain cases increased, cardiac indices of function, including CO,
EF, SV, and SW at both 10% and 5% O2 hypoxia, compared to
the vehicle group. However, the most notable changes in cardiac
function were observed at 5% O2 hypoxia. In small rodents,
the heart appears to compensate by increasing SV rather than
HR in response to hypoxia. One explanation for the lack of
chronotropic response in response to hypoxia is the cardio-
depressive effect of the anesthesia isoflurane, since previous
hypoxia studies in conscious animal showed increases in HR
with hypoxia. Animals experienced a slight increase in MAP at
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FIGURE 6 | In all panels, control perfusate is shown in blue and 5-HMF containing perfusate is shown in red. (A) Coronary blood flow in the isolated murine heart at
different oxygen tensions with control perfusate. (B) Coronary blood flow. (C) Heart rate (HR). (D) Left ventricular pressure at normoxia and hypoxia for control
perfusate and 5-HMF containing perfusate. ∗ represent statistically significant differences (P < 0.05) relative to normoxia.
FIGURE 7 | In all panels, control perfusate is shown in blue and 5-HMF containing perfusate is shown in red. (A) Glycolytic. (B) Glucose oxidation. (C) Lactate
oxidation rates at normoxia and hypoxia for control perfusate and 5-HMF containing perfusate. ∗ represent statistically significant differences (P < 0.05) relative to
normoxia.
15% O2; however, as O2 levels decreased, MAP decreased as
well. There are no significant differences between the treatment
groups. Additionally, by 5% FiO2 both treatments converge to a
MAP of 60 mmHg. Since there were no significant changes in
MAP, but there were improvements in CO and SV at 5% in the
presence of 5-HMF, there seems to be a volume dependent effect
induced by the 5-HMF during hypoxia, whereas the pressure
dependent effect appears to be determined by the SVR.
Vascular resistance significantly decreased for the 5-HMF
group, but not for the vehicle group relative to normoxia. As
multiple signaling pathways are activated by hypoxic stimuli
(such as O2, CO2, and lactate), they are integrated in different
vascular beds to modulate the response to hypoxia. Mild
reduction in lactate levels from the 5-HMF induced increase Hb-
O2 affinity during hypoxia appears to reduce the severe hypoxia-
induced mixed blood acid-base disorder observed in the vehicle
group. The hypoxic protective effects of 5-HMF-induced increase
in Hb-O2 affinity were more evident at 5% O2 hypoxia, when O2
upload in lungs was drastically challenged.
Effective arterial elastance (Ea), which reflects the vascular
impedance and is calculated as the mean end-ejection arterial
pressure normalized by the ventricular end-systolic pressure
(Kass and Kelly, 1992), correlated with the SVR changes. The
partial blunting of the measured SVR response to hypoxia in
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the vehicle groups is part of the compensatory mechanisms
to preserve vital organ O2 delivery by preferentially perfusing
vital organs (Cabrales et al., 2008; Tomasco et al., 2010). The
ratio of end-systolic pressure (Pes) to SV was constant under
a given steady state vascular impedance load and is indicative
of ventricular-arterial coupling. Additionally, during severe
hypoxia, ventricular-arterial coupling for the 5-HMF group was
significantly lower compared to normoxia and compared to the
vehicle group during severe hypoxia. Although the SV increased
for the 5-HMF group, the end systolic pressure is unresponsive to
hypoxia. These results are consistent with previous findings that
increasing Hb-O2 affinity during hypoxia resulted in a significant
increase in the diameter of arterioles in the microcirculation
(Dufu et al., 2017). This observed vasodilation is one explanation
for the differences in SVR and Ea between groups, since the
increased diameter can improve blood flow, and therefore,
oxygen delivery.
Treatment with 5-HMF induced an increase in Hb-O2 affinity
and a decrease in P50 relative to the vehicle group. Since
the hypoxic challenge used in the study was controlled based
on the inspired partial pressure of O2, blood O2 content
rather than pO2 becomes the critical determinant of tissue
O2 delivery to tissues (Yalcin and Cabrales, 2012). 5-HMF-
increase in SaO2 translated into an improved O2 delivery
to tissues, as suggested by Figure 3I. Histology analysis of
the heart shows that 5-HMF was effective in protecting the
myocardium from becoming hypoxic during hypoxia. However,
positive pimonidazole staining increased toward the apex of
the heart in both vehicle and 5-HMF group. This result was
expected due to the morphology and hemodynamics of coronary
circulation, in which the coronaries bring oxygenated blood
from the aortic sinus to provide O2 to the myocardium. As
such, regions farthest from the aortic sinus will encounter
the most significant deoxygenation. The apex of the heart
performs the most work, resulting in higher metabolic demands,
and thus faster oxygen depletion. By increasing the oxygen
affinity, 5-HMF increased O2 loading, offering better oxygenated
blood to cardiac tissue, especially where metabolic demands
are highest. A graphical representation of the expected oxygen
distribution in the coronary circulation is shown in Figure 5A.
The protective effect of increased O2 affinity is evident as the
total average of positive staining in the vehicle group was
nearly 60%, versus the approximate 40% positive staining for
the 5-HMF group. By pharmacologically shifting the SaO2 curve
to the left, 5-HMF reduced cardiac hypoxic tissue by nearly
60% during hypoxia.
The changes in microvascular dorsal skinfold saturation
(Figure 5B) also support the hypothesis that increased O2 affinity
allows for better oxygenated blood to arrive the more hypoxic
regions. Prior to 5-HMF administration, the distribution of
O2 during hypoxia appears relatively equal between arterioles
and venules. On the other hand, the O2 distribution during
hypoxia after 5-HMF infusion appears higher in the arterioles
than venules. As arterioles are prior to venules in the circulatory
system, the oxygen unloading has to be superior in the presence of
5-HMF in order for the venules to have a much smaller saturation
during hypoxia as compared to without 5-HMF. Furthermore,
since the arterial saturation, as measured through the arterial
line, was larger in the presence of 5-HMF, the decreased venule
saturation is not a result of a decreased amount of oxygen in
circulation. Due to the allosteric binding/unbinding of O2 to
Hb, if the Hb saturation is higher when the blood arrives to
the less hypoxic regions, then the unloading will be less than
if the saturation was lower. This secures most of the O2 to
the Hb as blood flows through the less hypoxic regions. As
blood reaches the more hypoxic regions, the oxygen gradient
is now sufficient to allow unloading from Hb, at which point
the allosteric unloading takes place, and the majority of the
O2 is then delivered to the more hypoxic tissues. As blood
arrives to the venous circulation, the Hb saturation is then
very low. This low venous Hb saturation can lead to a nitric
oxide dependent vasodilation of capacitance vessels (Redfors
et al., 2014), resulting in the observed decrease in SVR. In
contrast, in the absence of 5-HMF, Hb’s O2 affinity is lower,
resulting in a larger O2 unloading in the less hypoxic regions.
As blood reaches the more hypoxic regions, the gradient is still
large, however, the allosteric unbinding effect will be smaller,
resulting in less O2 unloading, resulting in an increased presence
of O2 in the venous circulation as shown in Figure 5B.
Despite these effects being studied in the skin, it is likely for
them to generalize to the coronary microcirculation as shown
in Figure 5A.
The isolated rat heart studies further support the idea
that the protective effect of the 5-HMF is a result of the
increased O2 affinity and not direct effects in coronary
flow or cardiac muscle metabolism. The use of an isolated
heart model eliminates confounding neurohumoral factors,
as the resulting cardiac function will be entirely dependent
on the contents of the perfusate. In the absence of blood,
perfusate with 5-HMF does not have any effects on cardiac
performance. The absence of significant differences in coronary
flow, HR, and pressure between the control perfusate and
5-HMF containing perfusate (Figures 6B–D) suggests that
there is no change in cardiac function in the absence of
the effects of increased Hb-O2 affinity. The similarity in
coronary blood flow in the presence and absence of 5-
HMF in the perfusate is consistent with the claim that the
observed decrease in SVR in the presence of 5-HMF is a result
of vasodilation due to the increased Hb-O2 in the arterial
circulation, and to vasodilation in the venous circulation due
to decreased venous saturation, not due to a vasoactive effect
of 5-HMF.
The isolated heart metabolic analysis is also supportive of
the fact that there is no change in cardiac muscle metabolism
in the presence of 5-HMF. The preserved glycolytic, glucose
oxidation and lactate oxidation rates between control and
5-HMF containing perfusates, in either hypoxic or normoxic
states, suggests that there is no direct effect of 5-HMF in
cardiac muscle glycolysis or glucose metabolism. Glycolysis is the
predominant source of energy during hypoxia (Whitmer et al.,
1978). Therefore, 5-HMF having no direct effect over glycolysis
is evidence that the superior cardiac function during hypoxia
and in the presence of 5-HMF, as measured by CO, SW, SV,
and EF, are a consequence of the decreased hypoxic damage in
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the presence of 5-HMF due to increases in Hb-O2 affinity in
the myocardial circulation, and not direct effects of 5-HMF in
myocardial metabolism.
In light of the results of this study, the possible health
benefits mediated by 5-HMF (e.g., from the diet) should be
considered. Information concerning the human daily dietary 5-
HMF exposure is scarce. Daily 5-HMF consumption data is
rare and previous research estimated a human ingest up to
150 mg of 5-HMFper day (Ulbricht et al., 1984); however, in
another recent report, it was suggested that a mean 5-HMF
intake of 6 mg per day was estimated for Spanish adolescents
(Delgado-Andrade et al., 2007). Intake of Honey, Jam, Fruit
cake, Tomato paste, Ketchup, Syrup, Fruit juice, Canned fruit,
and other foods containing 5-HMF in sufficient amounts could
increase Hb-O2 affinity and preserve O2 transport to cardiac
tissue during hypoxia. Although to achieve therapeutic doses of
5-HMF from foods, the amount of food required would need
to be significant.
One potential limitation of this study is that the experimental
results with fossorial animals, such as hamsters, could not
be extrapolated to other mammals and humans. While their
arterial pO2 at normoxia is lower compared to other rodents
and humans, their responses to hypoxia and hypercapnia are
more similar to those of non-fossorial rodents (Schlenker
and Goldman, 1985; Tomasco et al., 2010). At low O2
concentrations, their respiratory system responds by increasing
the frequency of respiration, with no changes in tidal volume
and little activation of stretch receptors (Tomasco et al.,
2010). In the experimental setup used in this study, animals
were connected to a mechanical ventilator, running at a
constant frequency with slight increases in peak inspiratory
pressures as O2 concentrations decreased. Therefore, specific
ventilatory responses to hypoxia in hamsters were dampened by
the used of mechanical ventilation. Hypoxia-induced reduced
metabolism has been shown to occur only in small species,
as allometric variation (mass-specific metabolic rate and O2
composition to body mass) is higher in smaller species as
compared to larger-size species (Kleiber, 1961). Therefore,
direct extrapolation of the degree of protection to hypoxia
that increases in Hb-O2 affinity provide still needs to be
evaluated in larger animals and humans. Another limitation
includes the cardioprotective effects of isoflurane, which has
been shown to help preserve cardiac function under different
conditions (Yildirim et al., 2009; Redfors et al., 2014). The
improvement in cardiac function in the presence of 5-HMF
compared to the vehicle control group indicates that there is
a beneficial improvement in cardiac function due to 5-HMF
in addition to any isoflurane cardioprotection effect, as any
isoflurane cardioprotection during hypoxia is present in the
vehicle group. Awake animal studies are required to determine
the significant benefits of 5-HMF in cardiac function independent
of isoflurane. The measurement of Hb-O2 affinity of blood
samples require dilution in a strongly buffered solution (TCS
Hemox solution, pH 7.3) and deoxygenation in the absence
of CO2. Therefore, the measurements of Hb-O2 affinity and
p50 values measured with the TCS Hemox Analyzer do not
reflect the Bohr and Haldane Effects, which are expected to
further decrease the Hb-O2 affinity as a function of the acid-
base status in vivo. Previous studies have replicated pH and
pCO2 changes induced by 10 and 5% O2 hypoxia in order
to better replicate the in vivo conditions eliminated by the
TCS Hemox Analyzer buffer and principle of operation. Results
indicated that the P50 values, independent of blood pCO2
and pH, are lowered by 3% at 10% O2 hypoxia and by 4%
at 5% O2 hypoxia (Zwart et al., 1982). Study of LVCF in
small animals are limited by their high HR which shortens
endocardial perfusion (Collins et al., 2003). Another important
note is that because their baseline HR is already high, there
is a limited rise in CO when needed. The CO response can
potentially be different in larger mammals, as there is more
flexibility in HR.
CONCLUSION
This study exposes that relatively small amount of 5-HMF
preserved LV cardiac function and reduced myocardial hypoxia
during severe hypoxic hypoxia (5% O2). Moreover, 5-HMF-
induced increase in Hb-O2 affinity improved tolerance to 5%
O2 hypoxia exposure. Therefore, 5-HMF-induced increase in
Hb-O2 affinity increased O2 delivery during hypoxia, thus
preserving MAP, HR, LVCF, and reduced lactate and myocardial
hypoxia. 5-HMF-induced increase in Hb-O2 affinity increased
blood O2 loading in the lungs and allowed for increased O2
delivery during hypoxia. The increase in O2 delivery during
hypoxia also decreased hypoxia in the myocardium. This
can be observed in the decreased hypoxic staining of the
myocardium in the presence of 5-HMF. The isolated heart
experiments suggest that 5-HMF is not conducive to changes
in myocardial glucose metabolism, suggesting that the decreased
hypoxic damage is a consequence of the increased affinity.
Furthermore, the hyperspectral analysis of the microcirculation
suggests increased oxygen delivery in the presence of 5-HMF,
further supporting the hypothesis that the decreased hypoxic
damage is tied to the 5-HMF-induced increase in oxygen affinity
of hemoglobin.
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